{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:23:37Z","timestamp":1759616617927,"version":"3.40.4"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T00:00:00Z","timestamp":1381449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00213-013-3295-2","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T17:31:15Z","timestamp":1381512675000},"page":"787-800","source":"Crossref","is-referenced-by-count":14,"title":["On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination"],"prefix":"10.1007","volume":"231","author":[{"given":"F. L.","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,11]]},"reference":[{"key":"3295_CR1","first-page":"133","volume":"36","author":"RAH Adan","year":"2013","unstructured":"Adan RAH (2013) Mechanisms underlying current and future anti-obesity drugs. TINS 36:133\u2013140","journal-title":"TINS"},{"key":"3295_CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(95)00051-L","volume":"275","author":"G Bagdy","year":"1995","unstructured":"Bagdy G, Makara GB (1995) Paraventricular nucleus controls 5-HT2C receptor-mediated corticosterone and prolactin but not oxytocin and penile erection responses. Eur J Pharmacol 275:301\u2013305","journal-title":"Eur J Pharmacol"},{"key":"3295_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(92)90279-D","volume":"229","author":"G Bagdy","year":"1992","unstructured":"Bagdy G, Kalogeras KT, Szemeredi K (1992) Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations. Eur J Pharmacol 229:9\u201314","journal-title":"Eur J Pharmacol"},{"key":"3295_CR4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083\u20131152","journal-title":"Neuropharmacology"},{"key":"3295_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.ne.07.030184.001521","volume":"7","author":"AI Basbaum","year":"1984","unstructured":"Basbaum AI, Fields HL (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7:309\u2013338","journal-title":"Annu Rev Neurosci"},{"key":"3295_CR6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0091-3057(91)90021-S","volume":"38","author":"IW Beczkowska","year":"1991","unstructured":"Beczkowska IW, Bodnar RJ (1991) Naloxone and serotonin receptor subtype antagonists: interactive effects upon deprivation-induced intake. Pharmacol Biochem Behav 38:605\u2013610","journal-title":"Pharmacol Biochem Behav"},{"key":"3295_CR7","doi-asserted-by":"crossref","first-page":"R945","DOI":"10.1152\/ajpregu.00275.2010","volume":"299","author":"NT Bello","year":"2010","unstructured":"Bello NT, Kemm MH, Ofeldt EM, Moran TH (2010) Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates. Am J Physiol Regul Integr Comp Physiol 299:R945\u2013R952","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3295_CR8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0024-3205(90)90320-Q","volume":"47","author":"D Benjamin","year":"1990","unstructured":"Benjamin D, Lal H, Meyerson LR (1990) The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze. Life Sci 47:195\u2013203","journal-title":"Life Sci"},{"key":"3295_CR9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.physbeh.2009.02.044","volume":"97","author":"KC Berridge","year":"2009","unstructured":"Berridge KC (2009) \u2018Liking\u2019 and \u2018wanting\u2019 food rewards: brain substrates and roles in eating disorders. Physiol Behav 97:537\u2013550","journal-title":"Physiol Behav"},{"key":"3295_CR10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2010.04.003","volume":"1350","author":"KC Berridge","year":"2010","unstructured":"Berridge KC, Ho C-Y, Richard JM, DiFeliceantonio AG (2010) The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res 1350:43\u201364","journal-title":"Brain Res"},{"key":"3295_CR11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0031-9384(98)00110-3","volume":"64","author":"S Bhavsar","year":"1998","unstructured":"Bhavsar S, Watkins J, Young A (1998) Synergy between amylin and cholecystokinin for inhibition of food intake in mice. Physiol Behav 64:557\u2013561","journal-title":"Physiol Behav"},{"key":"3295_CR12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.peptides.2004.01.006","volume":"25","author":"RJ Bodnar","year":"2004","unstructured":"Bodnar RJ (2004) Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides 25:697\u2013725","journal-title":"Peptides"},{"key":"3295_CR13","first-page":"349","volume":"58","author":"E Bojanowska","year":"2007","unstructured":"Bojanowska E, Nowak A (2007) Interactions between leptin and exendin-4, a glucagon-like peptide-1 agonist, in the regulation of food intake in the rat. J Physiol Pharmacol 58:349\u2013360","journal-title":"J Physiol Pharmacol"},{"key":"3295_CR14","first-page":"395","volume":"62","author":"E Bojanowska","year":"2011","unstructured":"Bojanowska E, Radziszewska E (2011) Combined stimulation of glucagon-like peptide-1 receptor agonist and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat. J Physiol Pharmacol 62:395\u2013402","journal-title":"J Physiol Pharmacol"},{"key":"3295_CR15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/meta.2001.24917","volume":"50","author":"CN Boozer","year":"2001","unstructured":"Boozer CN, Leibel RL, Love RJ, Cha MC, Aronne LJ (2001) Synergy of sibutramine and low dose leptin in treatment of diet-induced obesity in mice. Metabolism 50:889\u2013893","journal-title":"Metabolism"},{"key":"3295_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/026988119300700304","volume":"7","author":"PG Clifton","year":"1993","unstructured":"Clifton PG, Barnfield AM, Curzon G (1993) Effects of food deprivation and mCPP treatment on the microstructure of ingestive behaviour in male and female rats. J Psychopharmaol 7:257\u2013264","journal-title":"J Psychopharmaol"},{"key":"3295_CR17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s002130000504","volume":"152","author":"PG Clifton","year":"2000","unstructured":"Clifton PG, Lee MD, Dourish CT (2000) Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-amphetamine on feeding patterns in the rat. Psychopharmacology 152:256\u2013267","journal-title":"Psychopharmacology"},{"key":"3295_CR18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0091-3057(89)90422-X","volume":"33","author":"SJ Cooper","year":"1989","unstructured":"Cooper SJ, Turkish S (1989) Effects of naltrexone on food preference and concurrent behavioural responses in food deprived rats. Pharmacol Biochem Behav 33:17\u201320","journal-title":"Pharmacol Biochem Behav"},{"key":"3295_CR19","first-page":"143","volume-title":"Endorphins, opiates and behavioural processes","author":"SJ Cooper","year":"1988","unstructured":"Cooper SJ, Jackson A, Kirkham TC, Turkish S (1988) Endorphins, opiates and food intake. In: Rodgers RJ, Cooper SJ (eds) Endorphins, opiates and behavioural processes. Wiley, Chichester, pp 143\u2013186"},{"key":"3295_CR20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hup.470100504","volume":"10","author":"PJ Cowen","year":"1995","unstructured":"Cowen PJ, Sargent PA, Williams C, Goodall EM, Orlikov AB (1995) Hypophagic, endocrine and subjective responses to m-chlorophenylpiperazine in healthy men and women. Human Psychopharmacol 10:385\u2013391","journal-title":"Human Psychopharmacol"},{"key":"3295_CR21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nchembio.209","volume":"5","author":"JW Day","year":"2009","unstructured":"Day JW, Ottaway N, Patterson JT, Gelfanov V, Smiley D, Gidda J et al (2009) A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nat Chem Biol 5:749\u2013757","journal-title":"Nat Chem Biol"},{"issue":"Suppl 4","key":"3295_CR22","doi-asserted-by":"crossref","first-page":"449S","DOI":"10.1002\/j.1550-8528.1995.tb00212.x","volume":"3","author":"CT Dourish","year":"1995","unstructured":"Dourish CT (1995) Multiple serotonin receptors: opportunities for new treatments for obesity? Obesity Res 3(Suppl 4):449S\u2013462S","journal-title":"Obesity Res"},{"key":"3295_CR23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0091-3057(88)90173-6","volume":"29","author":"MP Fernandez-Tome","year":"1988","unstructured":"Fernandez-Tome MP, Gonzalez Y, Del Rio J (1988) Interaction between opioid agonists or naloxone and 5-HTP on feeding behaviour in food-deprived rats. Pharmacol Biochem Behav 29:387\u2013392","journal-title":"Pharmacol Biochem Behav"},{"key":"3295_CR24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14656560902824152","volume":"10","author":"KM Gadde","year":"2009","unstructured":"Gadde KM, Allison DB (2009) Combination therapy for obesity and metabolic disease. Expert Opin Pharmacother 10:921\u2013925","journal-title":"Expert Opin Pharmacother"},{"key":"3295_CR25","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4088\/JCP.v68n0809","volume":"68","author":"KM Gadde","year":"2007","unstructured":"Gadde KM, Yonish GM, Foust MS, Wagner HR (2007) Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study. J Clin Psychiatry 68:1226\u20131229","journal-title":"J Clin Psychiatry"},{"key":"3295_CR26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","volume":"95","author":"WT Garvey","year":"2012","unstructured":"Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA et al (2012) Two-year sustained weight loss and metabolic benefits with controlled release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomised, placebo-controlled, phase 3 extension study. Am J Clin Nutr 95:297\u2013308","journal-title":"Am J Clin Nutr"},{"key":"3295_CR27","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/npp.2012.128","volume":"37","author":"C Giuliano","year":"2012","unstructured":"Giuliano C, Robbins TW, Nathan PJ, Bullmore ET, Everitt BJ (2012) Inhibition of opioid transmission at the \u03bc-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology 37:2643\u20132652","journal-title":"Neuropsychopharmacology"},{"key":"3295_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/oby.2008.461","volume":"17","author":"FL Greenway","year":"2009","unstructured":"Greenway FL, Whitehouse MJ, Guttadauria M, Anderson JW, Atkinson RL, Fujioka K et al (2009) Rational design of a combination medication for the treatment of obesity. Obesity 17:30\u201339","journal-title":"Obesity"},{"key":"3295_CR29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00001756-199110000-00019","volume":"2","author":"G Griebel","year":"1991","unstructured":"Griebel G, MIsslin R, Pawlowski M, Vogel E (1991) m-Chlorophenylpiperazine enhances neophobic and anxious behavior in mice. NeuroReport 2:627\u2013629","journal-title":"NeuroReport"},{"key":"3295_CR30","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0091-3057(97)00318-3","volume":"58","author":"MM Hagan","year":"1997","unstructured":"Hagan MM, Holguin FD, Cabello CE, Hanscom DR, Moss DE (1997) Combined naloxone and fluoxetine on deprivation-induced binge-eating of palatable foods in rats. Pharmacol Biochem Behav 58:1103\u20131107","journal-title":"Pharmacol Biochem Behav"},{"key":"3295_CR31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0091-3057(98)00032-X","volume":"61","author":"JCG Halford","year":"1998","unstructured":"Halford JCG, Wanninayake SCD, Blundell JE (1998) Behavioural satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol Biochem Behav 61:159\u2013168","journal-title":"Pharmacol Biochem Behav"},{"key":"3295_CR32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003495-200767010-00004","volume":"67","author":"JCG Halford","year":"2007","unstructured":"Halford JCG, Harrold JA, Boyland EJ, Lawton CL, Blundell JE (2007) Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs 67:27\u201355","journal-title":"Drugs"},{"key":"3295_CR33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrendo.2010.19","volume":"6","author":"JCG Halford","year":"2010","unstructured":"Halford JCG, Boyland EJ, Blundell JE et al (2010) Pharmacological management of appetite expression in obesity. Nature Revs Endocrinol 6:255\u2013269","journal-title":"Nature Revs Endocrinol"},{"key":"3295_CR34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2012.01.007","volume":"63","author":"JA Harrold","year":"2012","unstructured":"Harrold JA, Dovey TM, Blundell JE, Halford JCG (2012) CNS regulation of appetite. Neuropharmacology 63:3\u201317","journal-title":"Neuropharmacology"},{"key":"3295_CR35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuropharm.2012.01.017","volume":"63","author":"DJ Heal","year":"2012","unstructured":"Heal DJ, Gosden J, Smith SL (2012) What is the prognosis for new centrally-acting anti-obesity drugs? Neuropharmacology 63:132\u2013146","journal-title":"Neuropharmacology"},{"key":"3295_CR36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1126\/science.1072327","volume":"297","author":"LK Heisler","year":"2002","unstructured":"Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL et al (2002) Activation of central melanocortin pathways by fenfluramine. Science 297:609\u2013611","journal-title":"Science"},{"key":"3295_CR37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.2003.tb03177.x","volume":"994","author":"LK Heisler","year":"2003","unstructured":"Heisler LK, Cowley MA, Kishi T, Tecott LH, Fan W, Low MJ et al (2003) Central serotonin and melanocortin pathways regulating energy homeostasis. Ann NY Acad Sci 994:169\u2013174","journal-title":"Ann NY Acad Sci"},{"key":"3295_CR38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuron.2006.06.004","volume":"51","author":"LK Heisler","year":"2006","unstructured":"Heisler LK, Jobst EE, Sutton GM, Zhou L, Borok E, Thornton-Jones Z et al (2006) Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51:239\u2013249","journal-title":"Neuron"},{"key":"3295_CR39","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0091-3057(01)00709-2","volume":"71","author":"KN Hewitt","year":"2002","unstructured":"Hewitt KN, Lee MD, Dourish CT, Clifton PG (2002) Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. Pharmacol Biochem Behav 71:691\u2013700","journal-title":"Pharmacol Biochem Behav"},{"key":"3295_CR40","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/npp.2011.303","volume":"37","author":"GA Higgins","year":"2012","unstructured":"Higgins GA, Silenicks LB, Robmann A, Rizos Z, Noble K, Soko AD et al (2012) The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control. Neuropsychopharmacology 37:1177\u20131191","journal-title":"Neuropsychopharmacology"},{"key":"3295_CR41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00213-012-2919-2","volume":"226","author":"GA Higgins","year":"2013","unstructured":"Higgins GA, Silenicks LB, Lau W, de Lannoy IAM, Lee DKH, Izakova J et al (2013) Evaluation of chemically diverse 5-HT2C receptor agonists on behaviours motivated by food and nicotine and on side-effect profiles. Psychopharmacology 226:475\u2013490","journal-title":"Psychopharmacology"},{"key":"3295_CR42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0361-9230(86)90192-9","volume":"17","author":"V Hinton","year":"1986","unstructured":"Hinton V, Rosofsky M, Granger J, Geary N (1986) Combined injection potentiates the satiety effects of pancreatic glucagon, cholecystokinin and bombesin. Brain Res Bull 17:615\u2013619","journal-title":"Brain Res Bull"},{"key":"3295_CR43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(25)06783-3","volume":"46","author":"D Hoyer","year":"1994","unstructured":"Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ et al (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157\u2013203","journal-title":"Pharmacol Rev"},{"key":"3295_CR44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0031-9384(03)00207-5","volume":"80","author":"Y Ishii","year":"2003","unstructured":"Ishii Y, Blundell JE, Halford JCG, Rodgers RJ (2003a) Palatability, food intake and the behavioural satiety sequence in male rats. Physiol Behav 80:37\u201347","journal-title":"Physiol Behav"},{"key":"3295_CR45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0031-9384(03)00066-0","volume":"79","author":"Y Ishii","year":"2003","unstructured":"Ishii Y, Blundell JE, Halford JCG, Rodgers RJ (2003b) Effects of systematic variation in presatiation and fasting on the behavioural satiety sequence in male rats. Physiol Behav 79:227\u2013238","journal-title":"Physiol Behav"},{"key":"3295_CR46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.physbeh.2004.01.009","volume":"81","author":"Y Ishii","year":"2004","unstructured":"Ishii Y, Blundell JE, Halford JCG, Upton N, Porter R, Johns A et al (2004) Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats. Physiol Behav 81:129\u2013140","journal-title":"Physiol Behav"},{"key":"3295_CR47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pbb.2010.07.020","volume":"97","author":"GA Kennett","year":"2010","unstructured":"Kennett GA, Clifton PG (2010) New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier? Pharmacol Biochem Behav 97:63\u201383","journal-title":"Pharmacol Biochem Behav"},{"key":"3295_CR48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1476-5381.1988.tb11508.x","volume":"94","author":"GA Kennett","year":"1988","unstructured":"Kennett GA, Curzon G (1988a) Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol 94:137\u2013147","journal-title":"Br J Pharmacol"},{"key":"3295_CR49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02431539","volume":"96","author":"GA Kennett","year":"1988","unstructured":"Kennett GA, Curzon G (1988b) Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors: hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology 96:93\u2013100","journal-title":"Psychopharmacology"},{"key":"3295_CR50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0014-2999(87)90561-9","volume":"141","author":"GA Kennett","year":"1987","unstructured":"Kennett GA, Dourish CT, Curzon G (1987) 5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol 141:429\u2013435","journal-title":"Eur J Pharmacol"},{"key":"3295_CR51","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0014-2999(89)90252-5","volume":"164","author":"GA Kennett","year":"1989","unstructured":"Kennett GA, Whitton P, Shah K, Curzon G (1989) Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol 164:445\u2013454","journal-title":"Eur J Pharmacol"},{"key":"3295_CR52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(99)00706-2","volume":"387","author":"G Kennett","year":"2000","unstructured":"Kennett G, Lightowler S, Trail B, Bright F, Bromidge S (2000) Effects or Ro 60-0175, a 5-HT2C receptor agonist, in three animals models of anxiety. Eur J Pharmcol 387:197\u2013204","journal-title":"Eur J Pharmcol"},{"key":"3295_CR53","doi-asserted-by":"crossref","unstructured":"Kirkham TC, Blundell JE (1984) Dual action of naloxone on feeding revealed by behavioural analysis: separate effects on initiation and termination of eating. Appetite 5:45\u201352","DOI":"10.1016\/S0195-6663(84)80049-5"},{"key":"3295_CR54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0091-3057(86)90241-8","volume":"25","author":"TC Kirkham","year":"1986","unstructured":"Kirkham TC, Blundell JE (1986) Effect of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine. Pharmacol Biochem Behav 25:123\u2013128","journal-title":"Pharmacol Biochem Behav"},{"key":"3295_CR55","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0091-3057(87)90158-4","volume":"26","author":"TC Kirkham","year":"1987","unstructured":"Kirkham TC, Blundell JE (1987) Effects of naloxone and naltrexone on meal patterns of freely-feeding rats. Pharmacol Biochem Behav 26:515\u2013520","journal-title":"Pharmacol Biochem Behav"},{"key":"3295_CR56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s002130000596","volume":"153","author":"TC Kirkham","year":"2001","unstructured":"Kirkham TC, Williams CM (2001) Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology 153:267\u2013270","journal-title":"Psychopharmacology"},{"key":"3295_CR57","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02245211","volume":"113","author":"SJ Kitchener","year":"1994","unstructured":"Kitchener SJ, Dourish CT (1994) An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats. Psychopharmacology 113:369\u2013377","journal-title":"Psychopharmacology"},{"key":"3295_CR58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00213-004-1864-0","volume":"176","author":"MD Lee","year":"2004","unstructured":"Lee MD, Somerville EM, Kennett GA, Dourish CT, Clifton PG (2004) Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice. Psychopharmacology 176:39\u201349","journal-title":"Psychopharmacology"},{"key":"3295_CR59","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1017\/S146114570900039X","volume":"12","author":"PJ Nathan","year":"2009","unstructured":"Nathan PJ, Bullmore ET (2009) From taste hedonics to motivational drive: central \u03bc-opioid receptors and binge-eating behaviour. Int J Neuropsychopharmacol 12:995\u20131008","journal-title":"Int J Neuropsychopharmacol"},{"key":"3295_CR60","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/oby.2012.66","volume":"20","author":"PM O\u2019Neill","year":"2012","unstructured":"O\u2019Neill PM, Smith SR, Weissman NJ, Fidler MC, Sanchez M, Zhang J et al (2012) Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity 20:1426\u20131436","journal-title":"Obesity"},{"key":"3295_CR61","first-page":"1117","volume":"10","author":"R Padwal","year":"2009","unstructured":"Padwal R (2009) Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity. Curr Opin Invest Drugs 10:1117\u20131125","journal-title":"Curr Opin Invest Drugs"},{"key":"3295_CR62","first-page":"A61","volume":"60","author":"M Paulik","year":"2011","unstructured":"Paulik M, Hamilton B, Hommel J, Holt L, Herring C, Stroup A et al (2011) Combined long-acting PYY and GLP-1 agonism synergistically normalizes weight and glucose in obese and diabetic mice. Diabetes 60:A61, 224-OR","journal-title":"Diabetes"},{"key":"3295_CR63","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(02)01551-0","volume":"442","author":"TA Pietras","year":"2002","unstructured":"Pietras TA, Rowland NE (2002) Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats. Eur J Pharmacol 442:237\u2013239","journal-title":"Eur J Pharmacol"},{"key":"3295_CR64","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/oby.2009.184","volume":"17","author":"E Ravussin","year":"2009","unstructured":"Ravussin E, Smith SR, Mitchell JA, Ahringarpure R, Shan K, Maier H et al (2009) Enhanced weight loss with pramlintide\/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring) 17:1736\u20131743","journal-title":"Obesity (Silver Spring)"},{"key":"3295_CR65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/oby.2010.136","volume":"19","author":"RD Reidelberger","year":"2011","unstructured":"Reidelberger RD, Haver AC, Apenteng BA, Anders KL, Steenson SM (2011) Effects of exendin-4 alone and with peptide YY (3\u201336) on food intake and body weight in diet-induced obese rats. Obes Silver Spring 19:121\u2013127","journal-title":"Obes Silver Spring"},{"key":"3295_CR66","first-page":"621","volume":"3","author":"RJ Rodgers","year":"1992","unstructured":"Rodgers RJ, Cole JC, Cobain MR, Daly P, Doran PJ, Eells JR et al (1992) Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behav Pharmacol 3:621\u2013634","journal-title":"Behav Pharmacol"},{"key":"3295_CR67","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.0953-816x.2001.01518.x","volume":"13","author":"RJ Rodgers","year":"2001","unstructured":"Rodgers RJ, Halford JCG, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JRS et al (2001) SB\u2013334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 13:1444\u20131452","journal-title":"Eur J Neurosci"},{"key":"3295_CR68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pbb.2010.03.001","volume":"97","author":"RJ Rodgers","year":"2010","unstructured":"Rodgers RJ, Holch P, Tallett AJ (2010) Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite. Pharmacol Biochem Behav 97:3\u201314","journal-title":"Pharmacol Biochem Behav"},{"key":"3295_CR69","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1242\/dmm.009621","volume":"5","author":"RJ Rodgers","year":"2012","unstructured":"Rodgers RJ, Tsch\u00f6ep MH, Wilding JPH (2012) Anti-obesity drugs: past, present and future. Dis Model Mech 5:621\u2013626","journal-title":"Dis Model Mech"},{"key":"3295_CR70","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1210\/en.2007-0898","volume":"148","author":"JD Roth","year":"2007","unstructured":"Roth JD, Coffey T, Jodka CM, Maier H, Athanacio JR, Mack CM et al (2007) Combination therapy with amylin and peptide YY3-36 in obese rodents: anorexigenic synergy and weight loss additivity. Endocrinology 148:6054\u20136061","journal-title":"Endocrinology"},{"key":"3295_CR71","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","volume":"105","author":"JD Roth","year":"2008","unstructured":"Roth JD, Roland BL, Cole RL, Trevaskis JL, Weyer C, Koda JE et al (2008a) Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci U S A 105:7257\u20137262","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3295_CR72","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/ijo.2008.91","volume":"32","author":"JD Roth","year":"2008","unstructured":"Roth JD, Trevaskis JL, Wilson J, Lei C, Athanacio J, Mack C et al (2008b) Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats. Int J Obesity 32:1201\u20131210","journal-title":"Int J Obesity"},{"key":"3295_CR73","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2010.01.027","volume":"1350","author":"JD Roth","year":"2010","unstructured":"Roth JD, Trevaskis JL, Turek VF, Parkes DG (2010) \u2018Weighing in\u2019 on synergy: preclinical research on neurohumoral anti-obesity combinations. Brain Res 1350:86\u201394","journal-title":"Brain Res"},{"key":"3295_CR74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s002130100910","volume":"159","author":"NE Rowland","year":"2001","unstructured":"Rowland NE, Mukherjee M, Roberston K (2001) Effects of the cannabinoid receptor antagonist SR141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology 159:111\u2013116","journal-title":"Psychopharmacology"},{"key":"3295_CR75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00499059","volume":"308","author":"R Samanin","year":"1979","unstructured":"Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S (1979) m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 308:159\u2013163","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"3295_CR76","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s002130050407","volume":"133","author":"PA Sargent","year":"1997","unstructured":"Sargent PA, Sharpley AL, Williams C, Goodall EM, Cowen PJ (1997) 5-HT2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology 133:309\u2013312","journal-title":"Psychopharmacology"},{"key":"3295_CR77","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0361-9230(90)90194-5","volume":"25","author":"KJ Simansky","year":"1990","unstructured":"Simansky KJ, Vaidya AH (1990) Behavioral mechanisms for the anorectic action of serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists. Brain Res Bull 25:953\u2013960","journal-title":"Brain Res Bull"},{"key":"3295_CR78","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1111\/j.1460-9568.2007.05567.x","volume":"25","author":"EM Somerville","year":"2007","unstructured":"Somerville EM, Horwood JM, Lee MD, Kennett GA, Clifton PG (2007) 5-HT2C receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice. Eur J Neurosci 25:3115\u20133124","journal-title":"Eur J Neurosci"},{"key":"3295_CR79","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bbr.2007.10.005","volume":"187","author":"AJ Tallett","year":"2008","unstructured":"Tallett AJ, Blundell JE, Rodgers RJ (2008a) Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food. Behav Brain Res 187:417\u2013427","journal-title":"Behav Brain Res"},{"key":"3295_CR80","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.physbeh.2008.02.009","volume":"94","author":"AJ Tallett","year":"2008","unstructured":"Tallett AJ, Blundell JE, Rodgers RJ (2008b) Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching. Physiol Behav 94:422\u2013431","journal-title":"Physiol Behav"},{"key":"3295_CR81","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pbb.2008.08.007","volume":"91","author":"AJ Tallett","year":"2009","unstructured":"Tallett AJ, Blundell JE, Rodgers RJ (2009a) Effects of acute low dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats. Pharmacol Biochem Behav 91:358\u2013366","journal-title":"Pharmacol Biochem Behav"},{"key":"3295_CR82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.physbeh.2009.01.022","volume":"97","author":"AJ Tallett","year":"2009","unstructured":"Tallett AJ, Blundell JE, Rodgers RJ (2009b) Night and day: diurnal differences in the behavioural satiety sequence in male rats. Physiol Behav 97:125\u2013130","journal-title":"Physiol Behav"},{"key":"3295_CR83","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbr.2009.10.004","volume":"207","author":"AJ Tallett","year":"2010","unstructured":"Tallett AJ, Blundell JE, Rodgers RJ (2010) Sibutramine and naloxone: infra-additive interaction in the regulation of appetite? Behav Brain Res 207:174\u2013181","journal-title":"Behav Brain Res"},{"key":"3295_CR84","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1210\/en.2005-0473","volume":"146","author":"T Talsania","year":"2005","unstructured":"Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL (2005) Peripheral exendin-4 and peptide YY3\u201336 synergistically reduce food intake through different mechanisms in mice. Endocrinology 146:3748\u20133756","journal-title":"Endocrinology"},{"key":"3295_CR85","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2012.04.001","volume":"63","author":"SP Vickers","year":"2012","unstructured":"Vickers SP, Clifton PG (2012) Animal models to explore the effects of CNS drugs on food intake and energy expenditure. Neuropharmacology 63:124\u2013131","journal-title":"Neuropharmacology"},{"key":"3295_CR86","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1476-5381.2011.01245.x","volume":"164","author":"SP Vickers","year":"2011","unstructured":"Vickers SP, Jackson HC, Cheetham SC (2011) The utility of animal models to evaluate novel anti-obesity agents. Br J Pharmacol 164:1248\u20131262","journal-title":"Br J Pharmacol"},{"key":"3295_CR87","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF02244883","volume":"116","author":"AES Walsh","year":"1994","unstructured":"Walsh AES, Smith KA, Oldman AD, Williams C, Goodall EM, Cowen PJ (1994) m-Chlorophenylpiperazine decreases food intake in a test meal. Psychopharmacology 116:120\u2013122","journal-title":"Psychopharmacology"},{"key":"3295_CR88","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1124\/jpet.107.131771","volume":"325","author":"SJ Ward","year":"2008","unstructured":"Ward SJ, Lefever TW, Jackson C, Tallarida RJ, Walker EA (2008) Effects of cannabinoid1 receptor antagonist and serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice. J Pharmacol Exp Ther 325:567\u2013576","journal-title":"J Pharmacol Exp Ther"},{"key":"3295_CR89","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1992.69","volume":"51","author":"M Weintraub","year":"1992","unstructured":"Weintraub M, Sundaresan PR, Madan M, Schuster B, Balder A, Lasagna L et al (1992) Long-term weight control study. I (weeks 0\u201334). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo. Clin Pharmacol Ther 51:586\u2013594","journal-title":"Clin Pharmacol Ther"},{"key":"3295_CR90","unstructured":"Weiss SM (1995) Pharmacological and behavioural examination of the defensive reactions of laboratory mice to the calls of the Tawny owl. Ph.D. thesis, School of Psychology, University of Leeds (UK)"},{"key":"3295_CR91","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF02244365","volume":"195","author":"GF Weiss","year":"1991","unstructured":"Weiss GF, Rogacki N, Fuel A, Buchen D, Suh JS, Wong DT et al (1991) Effect of hypothalamic and peripheral fluoxetine injection on natural patterns of macronutrient intake in the rat. Psychopharmacology (Berlin) 195:467\u2013476","journal-title":"Psychopharmacology (Berlin)"},{"key":"3295_CR92","first-page":"405","volume-title":"Handbook of anxiety and depression. A biological approach","author":"HGM Westenberg","year":"1994","unstructured":"Westenberg HGM, den Boer JA (1994) The neuropharmacology of anxiety: a review on the role of serotonin. In: Sitsen JMA, den Boer J (eds) Handbook of anxiety and depression. A biological approach. Marcel Dekker, New York, pp 405\u2013446"},{"key":"3295_CR93","author":"FL Wright","year":"2013","unstructured":"Wright FL, Rodgers RJ (2013) Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash. Psychopharmacology. doi: 10.1007\/s00213-013-3036-6","journal-title":"Psychopharmacology"},{"key":"3295_CR94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuropharm.2012.03.019","volume":"63","author":"AA Young","year":"2012","unstructured":"Young AA (2012) Brainstem sensing of meal-related signals in energy homeostasis. Neuropharmacology 63:31\u201345","journal-title":"Neuropharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3295-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-3295-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3295-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T16:36:02Z","timestamp":1746030962000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-3295-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,11]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["3295"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-3295-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2013,10,11]]}}}